Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistCoastal E-Liquid Laboratory/GC Vapors LLC was cited for manufacturing and distributing e-liquid tobacco products without required premarket authorization from the FDA. The company's products, sold through gcvapors.com, were deemed to violate the Family Smoking Prevention and Tobacco Control Act by failing to obtain marketing authorization orders as required for "new tobacco products" under section 910 of the Federal Food, Drug, and Cosmetic Act. The Center for Tobacco Products determined that these e-liquids, as products derived from tobacco and intended for human consumption, fell under FDA jurisdiction as of the August 8, 2016 deeming rule and therefore required compliance with applicable tobacco product regulations.